-
1
-
-
33747880085
-
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
-
DOI 10.1016/j.vaccine.2006.05.026, PII S0264410X06005937
-
Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL (2006) Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24: S26-S34. doi:10.1016/j.vaccine.2006.05.026. (Pubitemid 44293021)
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 3
-
-
Clifford, G.1
Franceschi, S.2
Diaz, M.3
Munoz, N.4
Villa, L.L.5
-
2
-
-
67949094324
-
Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline
-
doi:10.1186/1750-9378-4-8
-
Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Cancer 4: 8. doi:10.1186/1750-9378-4-8.
-
(2009)
Infect Agents Cancer
, vol.4
, pp. 8
-
-
Schiffman, M.1
Clifford, G.2
Buonaguro, F.M.3
-
3
-
-
0036221471
-
The causal relation between human papillomavirus and cervical cancer
-
Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265. doi:10.1136/jcp.55.4.244. (Pubitemid 34293391)
-
(2002)
Journal of Clinical Pathology
, vol.55
, Issue.4
, pp. 244-265
-
-
Bosch, F.X.1
Lorincz, A.2
Munoz, N.3
Meijer, C.J.L.M.4
Shah, K.V.5
-
4
-
-
0032840918
-
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
-
DOI 10.1002/(SICI)1096-9896(199909)189:1<12::A
-
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19. doi:10.1002/(SICI)1096-9896(199909)189:1〈12::AID- PATH431〉3.0.CO;2-F. (Pubitemid 29406813)
-
(1999)
Journal of Pathology
, vol.189
, Issue.1
, pp. 12-19
-
-
Walboomers, J.M.M.1
Jacobs, M.V.2
Manos, M.M.3
Bosch, F.X.4
Kummer, J.A.5
Shah, K.V.6
Snijders, P.J.F.7
Peto, J.8
Meijer, C.J.L.M.9
Munoz, N.10
-
5
-
-
2342595266
-
A causal role for human papillomavirus in head and neck cancer
-
doi:10.1016/S0140-6736(04)16194-1
-
Gillison ML, Lowy DR (2004) A causal role for human papillomavirus in head and neck cancer. Lancet 363: 1488-1489. doi:10.1016/S0140-6736(04)16194-1.
-
(2004)
Lancet
, vol.363
, pp. 1488-1489
-
-
Gillison, M.L.1
Lowy, D.R.2
-
6
-
-
0035031174
-
Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers
-
DOI 10.1097/00001622-200105000-00009
-
Gillison ML, Shah KV (2001) Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current Opinion in Oncology 13: 183-188. doi: 10.1097/00001622-200105000-00009. (Pubitemid 32433975)
-
(2001)
Current Opinion in Oncology
, vol.13
, Issue.3
, pp. 183-188
-
-
Gillison, M.L.1
Shah, K.V.2
-
7
-
-
0025886714
-
Human papillomaviruses in the pathogenesis of anogenital cancer
-
doi:10.1016/0042-6822(91)90816-T
-
Hausen zur H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13. doi:10.1016/0042-6822(91)90816-T.
-
(1991)
Virology
, vol.184
, pp. 9-13
-
-
Hausen Zur, H.1
-
8
-
-
0029041842
-
Prevalence of Human Papillomavirus in Cervical Cancer: A Worldwide Perspective
-
doi:10.1093/jnci/87.11.796
-
Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, et al. (1995) Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective. JNCI J Natl Cancer Inst 87: 796-802. doi:10.1093/jnci/87.11.796.
-
(1995)
JNCI J Natl Cancer Inst
, vol.87
, pp. 796-802
-
-
Bosch, F.X.1
Manos, M.M.2
Muñoz, N.3
Sherman, M.4
Jansen, A.M.5
-
9
-
-
33846459369
-
American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
-
Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, et al. (2007) American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA: A Cancer Journal for Clinicians 57: 7-28. doi:10.3322/canjclin.57.1.7. (Pubitemid 46148088)
-
(2007)
Ca-A Cancer Journal for Clinicians
, vol.57
, Issue.1
, pp. 7-28
-
-
Saslow, D.1
Castle, P.E.2
Cox, J.T.3
Davey, D.D.4
Einstein, M.H.5
Ferris, D.G.6
Goldie, S.J.7
Harper, D.M.8
Kinney, W.9
Moscicki, A.-B.10
Noller, K.L.11
Wheeler, C.M.12
Ades, T.13
Andrews, K.S.14
Doroshenk, M.K.15
Kahn, K.G.16
Schmidt, C.17
Shafey, O.18
Smith, R.A.19
Partridge, E.E.20
Garcia, F.21
more..
-
10
-
-
1342280969
-
Sexually Transmitted Diseases among American Youth: Incidence and Prevalence Estimates, 2000
-
Weinstock H, Berman S, Cates W (2004) Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000. Perspectives on Sexual and Reproductive Health 36: 6-10. doi:10.1363/3600604. (Pubitemid 38258322)
-
(2004)
Perspectives on Sexual and Reproductive Health
, vol.36
, Issue.1
, pp. 6-10
-
-
Weinstock, H.1
Berman, S.2
Cates Jr., W.3
-
11
-
-
0038119753
-
The natural history of type-specific human papillomavirus infections in female university students
-
Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, et al. (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12: 485-490. (Pubitemid 36713640)
-
(2003)
Cancer Epidemiology Biomarkers and Prevention
, vol.12
, Issue.6
, pp. 485-490
-
-
Richardson, H.1
Kelsall, G.2
Tellier, P.3
Voyer, H.4
Abrahamowicz, M.5
Ferenczy, A.6
Coutlee, F.7
Franco, E.L.8
-
12
-
-
78650748371
-
Persistence of human papillomavirus infection: Keys to malignant progression
-
doi:10.1016/j.tim.2010.10.002
-
Bodily J, Laimins LA (2011) Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 19: 33-39. doi:10.1016/j.tim.2010.10.002.
-
(2011)
Trends Microbiol
, vol.19
, pp. 33-39
-
-
Bodily, J.1
Laimins, L.A.2
-
13
-
-
0035832483
-
Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study
-
DOI 10.1016/S0140-6736(00)04956-4
-
Woodman CB, Collins S, Winter H, Bailey A, Ellis J, et al. (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831-1836. doi:10.1016/S0140-6736(00) 04956-4. (Pubitemid 32539115)
-
(2001)
Lancet
, vol.357
, Issue.9271
, pp. 1831-1836
-
-
Woodman, C.B.J.1
Collins, S.2
Winter, H.3
Bailey, A.4
Ellis, J.5
Prior, P.6
Yates, M.7
Rollason, T.P.8
Young, L.S.9
-
14
-
-
0037251859
-
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis
-
Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, et al. (2003) Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis. JNCI J Natl Cancer Inst 95: 46-52. doi:10.1093/jnci/95.1.46. (Pubitemid 36124295)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.1
, pp. 46-52
-
-
Sherman, M.E.1
Lorincz, A.T.2
Scott, D.R.3
Wacholder, S.4
Castle, P.E.5
Glass, A.G.6
Mielzynska-Lohnas, I.7
Rush, B.B.8
Schiffman, M.9
-
15
-
-
33644938245
-
Immune responses to human papillomavirus
-
doi:10.1016/j.vaccine.2005.09.002
-
Stanley M (2006) Immune responses to human papillomavirus. Vaccine 24 Suppl 1: S16-S22. doi:10.1016/j.vaccine.2005.09.002.
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 1
-
-
Stanley, M.1
-
16
-
-
72649101491
-
Immune responses to human papilloma viruses
-
StanleyMA (2009) Immune responses to human papilloma viruses. Indian JMed Res 130: 266-276.
-
(2009)
Indian JMed Res
, vol.130
, pp. 266-276
-
-
Stanley, M.A.1
-
17
-
-
72249089735
-
Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells
-
doi:10.1158/0008-5472.CAN-09-0550
-
Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, et al. (2009) Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Cancer Res 69: 8718-8725. doi:10.1158/0008-5472.CAN-09-0550.
-
(2009)
Cancer Res
, vol.69
, pp. 8718-8725
-
-
Rincon-Orozco, B.1
Halec, G.2
Rosenberger, S.3
Muschik, D.4
Nindl, I.5
-
18
-
-
70349240660
-
Human papillomaviruses and the interferon response
-
doi:10.1089/jir.2009.0075
-
Beglin M, Melar-New M, Laimins L (2009) Human papillomaviruses and the interferon response. J Interferon Cytokine Res 29: 629-635. doi:10.1089/jir. 2009.0075.
-
(2009)
J Interferon Cytokine Res
, vol.29
, pp. 629-635
-
-
Beglin, M.1
Melar-New, M.2
Laimins, L.3
-
19
-
-
0032128003
-
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
-
Ronco LV, Karpova AY, Vidal M, Howley PM (1998) Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12: 2061-2072. doi:10.1101/gad.12.13.2061. (Pubitemid 28323879)
-
(1998)
Genes and Development
, vol.12
, Issue.13
, pp. 2061-2072
-
-
Ronco, L.V.1
Karpova, A.Y.2
Vidal, M.3
Howley, P.M.4
-
20
-
-
0034629279
-
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
-
doi: 10.1074/jbc.275.10.6764
-
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, et al. (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275: 6764-6769. doi: 10.1074/jbc.275.10. 6764.
-
(2000)
J Biol Chem
, vol.275
, pp. 6764-6769
-
-
Park, J.S.1
Kim, E.J.2
Kwon, H.J.3
Hwang, E.S.4
Namkoong, S.E.5
-
21
-
-
0033526860
-
The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
-
DOI 10.1006/viro.1999.9771
-
Barnard P, McMillan NA (1999) The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259: 305-313. doi:10.1006/viro.1999.9771. (Pubitemid 29393381)
-
(1999)
Virology
, vol.259
, Issue.2
, pp. 305-313
-
-
Barnard, P.1
McMillan, N.A.J.2
-
22
-
-
84871484827
-
The broad-spectrum antiviral functions of IFIT and IFITM proteins
-
doi:10.1038/nri3344
-
Diamond MS, Farzan M (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13: 46-57. doi:10.1038/nri3344.
-
(2013)
Nat Rev Immunol
, vol.13
, pp. 46-57
-
-
Diamond, M.S.1
Farzan, M.2
-
23
-
-
84888015374
-
IFITMs restrict the replication of multiple pathogenic viruses
-
doi:10.1016/j.jmb.2013.09.024
-
Perreira JM, Chin CR, Feeley EM, Brass AL (2013) IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol 425: 4937-4955. doi:10.1016/j.jmb.2013.09.024.
-
(2013)
J Mol Biol
, vol.425
, pp. 4937-4955
-
-
Perreira, J.M.1
Chin, C.R.2
Feeley, E.M.3
Brass, A.L.4
-
24
-
-
72549116887
-
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus
-
doi:10.1016/j.cell.2009.12.017
-
Brass AL, Huang I-C, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254. doi:10.1016/j.cell.2009.12.017.
-
(2009)
Cell
, vol.139
, pp. 1243-1254
-
-
Brass, A.L.1
Huang, I.-C.2
Benita, Y.3
John, S.P.4
Krishnan, M.N.5
-
25
-
-
79551532447
-
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
-
doi:10.1371/journal.ppat.1001258
-
Huang I-C, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus. PLoS Pathog 7: e1001258. doi:10.1371/journal.ppat.1001258.
-
(2011)
PLoS Pathog
, vol.7
-
-
Huang, I.-C.1
Bailey, C.C.2
Weyer, J.L.3
Radoshitzky, S.R.4
Becker, M.M.5
-
26
-
-
84862909215
-
ISG56 and IFITM1 proteins inhibit hepatitis C virus replication
-
doi:10.1128/JVI.05633-11
-
Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, et al. (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85: 12881-12889. doi:10.1128/JVI.05633-11.
-
(2011)
J Virol
, vol.85
, pp. 12881-12889
-
-
Raychoudhuri, A.1
Shrivastava, S.2
Steele, R.3
Kim, H.4
Ray, R.5
-
27
-
-
79551715390
-
The IFITM proteins inhibit HIV-1 infection
-
doi:10.1128/JVI.01531-10
-
Lu J, Pan Q, Rong L, He W, Liu S-L, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126-2137. doi:10.1128/JVI.01531-10.
-
(2011)
J Virol
, vol.85
, pp. 2126-2137
-
-
Lu, J.1
Pan, Q.2
Rong, L.3
He, W.4
Liu, S.-L.5
-
28
-
-
84880599167
-
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus
-
doi:10.1128/JVI.03382-12
-
Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, et al. (2013) IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87: 8451-8464. doi:10.1128/JVI.03382-12.
-
(2013)
J Virol
, vol.87
, pp. 8451-8464
-
-
Mudhasani, R.1
Tran, J.P.2
Retterer, C.3
Radoshitzky, S.R.4
Kota, K.P.5
-
29
-
-
84879048489
-
Interferoninducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry
-
doi:10.1074/jbc.M112.438515
-
Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH (2013) Interferoninducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 288: 17261-17271. doi:10.1074/jbc.M112.438515.
-
(2013)
J Biol Chem
, vol.288
, pp. 17261-17271
-
-
Anafu, A.A.1
Bowen, C.H.2
Chin, C.R.3
Brass, A.L.4
Holm, G.H.5
-
30
-
-
84894247386
-
Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model
-
doi:10.1371/journal.pone.0080723
-
Everitt AR, Clare S, McDonald JU, Kane L, Harcourt K, et al. (2013) Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model. PLoS ONE 8: e80723. doi:10.1371/journal.pone.0080723.
-
(2013)
PLoS ONE
, vol.8
-
-
Everitt, A.R.1
Clare, S.2
McDonald, J.U.3
Kane, L.4
Harcourt, K.5
-
31
-
-
0037119997
-
Atomic model of the papillomavirus capsid
-
doi:10.1093/emboj/cdf494
-
Modis Y, Trus BL, Harrison SC (2002) Atomic model of the papillomavirus capsid. The EMBO Journal 21: 4754-4762. doi:10.1093/emboj/cdf494.
-
(2002)
The EMBO Journal
, vol.21
, pp. 4754-4762
-
-
Modis, Y.1
Trus, B.L.2
Harrison, S.C.3
-
32
-
-
77952306622
-
Current understanding of the mechanism of HPV infection
-
doi:10.1016/j.ygyno.2010.04.004
-
Schiller JT, Day PM, Kines RC (2010) Current understanding of the mechanism of HPV infection. Gynecol Oncol 118: S12-S17. doi:10.1016/j.ygyno. 2010.04.004.
-
(2010)
Gynecol Oncol
, vol.118
-
-
Schiller, J.T.1
Day, P.M.2
Kines, R.C.3
-
33
-
-
30344481121
-
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes
-
DOI 10.1128/JVI.80.2.759-768.2006
-
Kämper N, Day PM, Nowak T, Selinka H-C, Florin L, et al. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80: 759-768. doi:10.1128/JVI.80. 2.759-768.2006. (Pubitemid 43062888)
-
(2006)
Journal of Virology
, vol.80
, Issue.2
, pp. 759-768
-
-
Kamper, N.1
Day, P.M.2
Nowak, T.3
Selinka, H.-C.4
Florin, L.5
Bolscher, J.6
Hilbig, L.7
Schiller, J.T.8
Sapp, M.9
-
34
-
-
84861207605
-
Entry of Human Papillomavirus Type 16 by Actin-Dependent, Clathrin- and Lipid Raft-Independent Endocytosis
-
doi:10.1371/journal.ppat.1002657
-
Schelhaas M, Shah B, Holzer M, Blattmann P, Kühling L, et al. (2012) Entry of Human Papillomavirus Type 16 by Actin-Dependent, Clathrin- and Lipid Raft-Independent Endocytosis. PLoS Pathog 8: e1002657. doi:10.1371/journal.ppat. 1002657.
-
(2012)
PLoS Pathog
, vol.8
-
-
Schelhaas, M.1
Shah, B.2
Holzer, M.3
Blattmann, P.4
Kühling, L.5
-
35
-
-
84880351887
-
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry
-
doi:10.1128/JVI.00370-13
-
Spoden G, Kühling L, Cordes N, Frenzel B, Sapp M, et al. (2013) Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol 87: 7765-7773. doi:10.1128/JVI.00370-13.
-
(2013)
J Virol
, vol.87
, pp. 7765-7773
-
-
Spoden, G.1
Kühling, L.2
Cordes, N.3
Frenzel, B.4
Sapp, M.5
-
36
-
-
80055078235
-
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
-
doi:10.1371/journal.ppat.1002337
-
Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry. PLoS Pathog 7: e1002337. doi:10.1371/journal.ppat.1002337.
-
(2011)
PLoS Pathog
, vol.7
-
-
Feeley, E.M.1
Sims, J.S.2
John, S.P.3
Chin, C.R.4
Pertel, T.5
-
38
-
-
0346688642
-
Efficient intracellular assembly of papillomaviral vectors
-
doi:10.1128/JVI.78.2.751-757.2004
-
Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol. doi:10.1128/JVI.78.2.751-757.2004.
-
(2004)
J Virol
-
-
Buck, C.B.1
Pastrana, D.V.2
Lowy, D.R.3
Schiller, J.T.4
-
39
-
-
84884826544
-
Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
-
doi:10.1371/journal.pone.0076469
-
Qian Z, Dominguez SR, Holmes KV (2013) Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation. PLoS ONE 8: e76469. doi:10.1371/journal.pone.0076469.
-
(2013)
PLoS ONE
, vol.8
-
-
Qian, Z.1
Dominguez, S.R.2
Holmes, K.V.3
-
40
-
-
0023852747
-
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
-
Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771. doi:10.1083/jcb.106.3.761. (Pubitemid 18089976)
-
(1988)
Journal of Cell Biology
, vol.106
, Issue.3
, pp. 761-771
-
-
Boukamp, P.1
Petrussevska, R.T.2
Breitkreutz, D.3
Hornung, J.4
Markham, A.5
Fusenig, N.E.6
-
41
-
-
84873080242
-
Human papillomavirus infection is inhibited by host autophagy in primary human keratinocytes
-
doi:10.1016/j.virol.2012.12.004
-
Griffin LM, Cicchini L, Pyeon D (2013) Human papillomavirus infection is inhibited by host autophagy in primary human keratinocytes. Virology 437: 12- 19. doi:10.1016/j.virol.2012.12.004.
-
(2013)
Virology
, vol.437
, pp. 12-19
-
-
Griffin, L.M.1
Cicchini, L.2
Pyeon, D.3
-
42
-
-
34250311964
-
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers
-
DOI 10.1158/0008-5472.CAN-06-3619
-
Pyeon D, Newton MA, Lambert PF, Boon den JA, Sengupta S, et al. (2007) Fundamental differences in cell cycle deregulation in human papillomaviruspositive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 67: 4605-4619. doi:10.1158/0008-5472.CAN-06-3619. (Pubitemid 46910165)
-
(2007)
Cancer Research
, vol.67
, Issue.10
, pp. 4605-4619
-
-
Pyeon, D.1
Newton, M.A.2
Lambert, P.F.3
Den, B.J.A.4
Sengupta, S.5
Marsit, C.J.6
Woodworth, C.D.7
Connor, J.P.8
Haugen, T.H.9
Smith, E.M.10
Kelsey, K.T.11
Turek, L.P.12
Ahlquist, P.13
-
43
-
-
61449235414
-
Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression
-
doi:10.1371/journal.ppat.1000318
-
Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF (2009) Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression. PLoS Pathog 5: e1000318. doi:10.1371/journal.ppat.1000318.
-
(2009)
PLoS Pathog
, vol.5
-
-
Pyeon, D.1
Pearce, S.M.2
Lank, S.M.3
Ahlquist, P.4
Lambert, P.F.5
-
44
-
-
0019853949
-
Evidence that types I and II interferons have different receptors
-
Branca AA, Baglioni C (1981) Evidence that types I and II interferons have different receptors. Nature 294: 768-770. doi: 10.1038/294768a0. (Pubitemid 12174452)
-
(1981)
Nature
, vol.294
, Issue.5843
, pp. 768-770
-
-
Branca, A.A.1
Baglioni, C.2
-
45
-
-
4644298997
-
Adenovirus endocytosis
-
DOI 10.1002/jgm.553
-
Meier O, Greber UF (2004) Adenovirus endocytosis. The Journal of Gene Medicine 6: S152-S163. doi:10.1002/jgm.553. (Pubitemid 40228024)
-
(2004)
Journal of Gene Medicine
, vol.6
, Issue.SUPPL. 1
-
-
Meier, O.1
Greber, U.F.2
-
46
-
-
30344435010
-
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion
-
DOI 10.1128/JVI.80.2.710-722.2006
-
Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80: 710-722. doi:10.1128/JVI.80.2.710-722.2006. (Pubitemid 43062884)
-
(2006)
Journal of Virology
, vol.80
, Issue.2
, pp. 710-722
-
-
Ryckman, B.J.1
Jarvis, M.A.2
Drummond, D.D.3
Nelson, J.A.4
Johnson, D.C.5
-
47
-
-
84876349734
-
The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry
-
doi:10.1016/j.chom.2013.03.006
-
Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang I-C, et al. (2013) The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13: 452-464. doi:10.1016/j.chom.2013.03. 006.
-
(2013)
Cell Host Microbe
, vol.13
, pp. 452-464
-
-
Amini-Bavil-Olyaee, S.1
Choi, Y.J.2
Lee, J.H.3
Shi, M.4
Huang, I.-C.5
-
48
-
-
23944516870
-
The host type I interferon response to viral and bacterial infections
-
DOI 10.1038/sj.cr.7290309
-
Perry AK, Chen G, Zheng D, Tang H, Cheng G (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15: 407-422. doi:10.1038/sj.cr.7290309. (Pubitemid 41642869)
-
(2005)
Cell Research
, vol.15
, Issue.6
, pp. 407-422
-
-
Perry, A.K.1
Chen, G.2
Zheng, D.3
Tang, H.4
Cheng, G.5
-
49
-
-
0032417696
-
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
-
DOI 10.1073/pnas.95.26.15623
-
Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95: 15623-15628. doi: 10.1073/pnas.95.26.15623. (Pubitemid 29018750)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.26
, pp. 15623-15628
-
-
Der, S.D.1
Zhou, A.2
Williams, B.R.G.3
Silverman, R.H.4
-
50
-
-
0025605058
-
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: Changes of proliferation, melanin synthesis, and immunophenotype
-
doi:10.1111/1523-1747.ep12875837
-
Garbe C, Krasagakis K, Zouboulis CC, Schröder K, Krüger S, et al. (1990) Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol 95: 231S-237S. doi:10.1111/1523-1747.ep12875837.
-
(1990)
J Invest Dermatol
, vol.95
-
-
Garbe, C.1
Krasagakis, K.2
Zouboulis, C.C.3
Schröder, K.4
Krüger, S.5
-
51
-
-
0027496645
-
Stepwise dismantling of adenovirus 2 during entry into cells
-
DOI 10.1016/0092-8674(93)90382-Z
-
Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477-486. doi: 10.1016/0092-8674(93)90382-Z. (Pubitemid 23335073)
-
(1993)
Cell
, vol.75
, Issue.3
, pp. 477-486
-
-
Greber, U.F.1
Willetts, M.2
Webster, P.3
Helenius, A.4
-
52
-
-
13444311651
-
Adenovirus protein VI mediates membrane disruption following capsid disassembly
-
DOI 10.1128/JVI.79.4.1992-2000.2005
-
Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79: 1992-2000. doi:10.1128/JVI.79.4.1992-2000.2005. (Pubitemid 40204556)
-
(2005)
Journal of Virology
, vol.79
, Issue.4
, pp. 1992-2000
-
-
Wiethoff, C.M.1
Wodrich, H.2
Gerace, L.3
Nemerow, G.R.4
-
53
-
-
56149117291
-
Infectious Adenovirus Type 2 Transport Through Early but not Late Endosomes
-
doi:10.1111/j.1600-0854.2008.00835.x
-
Gastaldelli M, Imelli N, Boucke K, Amstutz B, Meier O, et al. (2008) Infectious Adenovirus Type 2 Transport Through Early but not Late Endosomes. Traffic 9: 2265-2278. doi:10.1111/j.1600-0854.2008.00835.x.
-
(2008)
Traffic
, vol.9
, pp. 2265-2278
-
-
Gastaldelli, M.1
Imelli, N.2
Boucke, K.3
Amstutz, B.4
Meier, O.5
-
54
-
-
39149093012
-
Entry route of HCMV into endothelial cells
-
doi:10.1016/j.jcv.2007.12.002
-
Sinzger C (2008) Entry route of HCMV into endothelial cells. J Clin Virol 41: 174-179. doi:10.1016/j.jcv.2007.12.002.
-
(2008)
J Clin Virol
, vol.41
, pp. 174-179
-
-
Sinzger, C.1
-
55
-
-
0026787140
-
Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface
-
doi: 10.1016/0042-6822(92)90200-9
-
Compton T, Nepomuceno RR, Nowlin DM (1992) Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191: 387-395. doi: 10.1016/0042-6822(92)90200-9.
-
(1992)
Virology
, vol.191
, pp. 387-395
-
-
Compton, T.1
Nepomuceno, R.R.2
Nowlin, D.M.3
|